Cure8 research brief
Surgical approach to creating an IPAA (j-pouch) affects timing and number of operations and recovery; trends toward more staged procedures may reflect increasing disease severity and preoperative treatment patterns that matter to patients planning colectomy and pouch surgery.
Adults with ulcerative colitis considering colectomy/IPAA, postoperative pouch patients, colorectal surgeons, and clinicians managing surgical referrals.
This article reports a retrospective cohort study of privately insured adults with ulcerative colitis who underwent ileal pouch–anal anastomosis (IPAA) between 2007 and 2023. The authors compared use of traditional 2-stage, modified 2-stage, and 3-stage IPAA and examined markers of disease severity at the time of pouch creation.
Across 4,039 patients, traditional 2-stage IPAA declined over time while both 3-stage and modified 2-stage approaches increased. The shift toward 3-stage and modified 2-stage procedures occurred alongside rising markers of disease severity at the time of surgery, including greater preoperative exposure to advanced therapies.
The study used an administrative insurance database and reports annualized changes in procedure proportions and preoperative therapy exposure. Limitations noted by the authors include possible misclassification and questions about generalizability beyond privately insured, non-elderly adults.
This brief summarizes the article abstract and does not represent a review of the full published manuscript.
Findings come from a retrospective analysis of a privately insured administrative database (non-elderly adults) and are grounded in the article abstract; the authors note potential misclassification and limited generalizability.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This study reports real-world outcomes with granulocyte and monocyte adsorptive apheresis (GMA) in patients with refractory IBD, showing steroid-free remission by week 14 in about one-third of patients and continued...
Surgery for IBD has become less common since modern biologic therapies, but a noticeable number of patients—especially with Crohn’s disease and poor nutrition—still progress to operations. Understanding who remains at...
The review examines whether removing the appendix could change the course of ulcerative colitis — a potential surgical option that might lower colectomy or hospitalization risk in some scenarios but also carries...
